Is a complete TRAW research report available?

No complete published report is available for Traws Pharma, Inc. (TRAW) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Traws Pharma, Inc. (TRAW)

NASDAQ: TRAW · USD

$0.35

-0.01 (-3.6%)· Recorded snapshot

Market cap	5.4M
Net income (ttm)	-16.4M
EPS (ttm)	-$1.47
Shares out	15.4M
Volume	27,618
Beta	1.53

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -16.4M
EPS (ttm): -$1.47
Market cap: 5.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Держать

Metric	Value
Amount currency	USD
CIK code	0001130598
Company name	Traws Pharma, Inc.
Country	United States
Country code	US
CUSIP number	68232V884
Earnings date	2026-11-12
Earnings time	bmo
Employees	7
Employees change	-11
Employees growth	-61.11%
Enterprise value	$405,928
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	1998
Industry	Biotechnology
IPO date	2013-07-25
Is primary listing	Yes
Is SPAC	No
ISIN number	US68232V8845
Last 10-K release date	2026-04-15
Last earnings date	2026-08-14
Last refreshed	2026-10-28
Last stock split date	2024-09-23
Last stock split type	Reverse
Market cap	$5.4M
Market cap category	Nano-Cap
Next earnings date	2026-11-12
Options	No
Price	$0.35
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	TRAW
U.S. state	Pennsylvania
Website	https://www.trawspharma.com

Metric

Value

Amount currency

USD

CIK code

0001130598

Company name

Traws Pharma, Inc.

Country

United States

Country code

CUSIP number

68232V884

Earnings date

2026-11-12

Earnings time

bmo

Employees

Employees change

-11

Employees growth

-61.11%

Enterprise value

$405,928

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

1998

Industry

Biotechnology

IPO date

2013-07-25

Is primary listing

Yes

Is SPAC

ISIN number

US68232V8845

Last 10-K release date

2026-04-15

Last earnings date

2026-08-14

Last refreshed

2026-10-28

Last stock split date

2024-09-23

Last stock split type

Reverse

Market cap

$5.4M

Market cap category

Nano-Cap

Next earnings date

2026-11-12

Options

Price

$0.35

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

TRAW

U.S. state

Pennsylvania

Website

https://www.trawspharma.com

Metric	Value
Earnings yield	-417.6%
FCF / EV yield	-2,767.63%
FCF yield	-299.55%
P/B ratio	3.3x
Sector forward P/E	23.53x
Sector P/E	51.01x

Metric

Value

Earnings yield

-417.6%

FCF / EV yield

-2,767.63%

FCF yield

-299.55%

P/B ratio

3.3x

Sector forward P/E

23.53x

Sector P/E

51.01x

Metric	Value
Profit per employee	$-2.3M
Profitable years	1
ROA	-99.4%
ROA (5Y)	-44.45%
ROCE	-1,241.73%
ROE	-433.36%
ROIC	-270.57%

Metric

Value

Profit per employee

$-2.3M

Profitable years

ROA

-99.4%

ROA (5Y)

-44.45%

ROCE

-1,241.73%

ROE

-433.36%

ROIC

-270.57%

Metric	Value
EPS growth years	1
Net income growth years	1
Revenue growth	1,134.51%
Revenue growth years	1

Metric

Value

EPS growth years

Net income growth years

Revenue growth

1,134.51%

Revenue growth years

Metric	Value
Depreciation and amortization	$147,000
EBIT	$-21.5M
EBITDA	$-21.4M
EPS	$-1.47
FCF per share	$-1.10
Financing cash flow	$11.4M
Free cash flow	$-16.8M
Free cash flow minus SBC	$-18.8M
Investing cash flow	$-2.6M
Net cash flow	$-8.1M
Net income	$-16.4M
Operating cash flow minus SBC	$-18.8M
Operating income	$-21.5M
Stock-based compensation	$1.9M

Metric

Value

Depreciation and amortization

$147,000

EBIT

$-21.5M

EBITDA

$-21.4M

EPS

$-1.47

FCF per share

$-1.10

Financing cash flow

$11.4M

Free cash flow

$-16.8M

Free cash flow minus SBC

$-18.8M

Investing cash flow

$-2.6M

Net cash flow

$-8.1M

Net income

$-16.4M

Operating cash flow minus SBC

$-18.8M

Operating income

$-21.5M

Stock-based compensation

$1.9M

Metric	Value
Altman Z-Score	-84.72
Book value per share	$0.11
Debt / equity	0
Long-term assets	$2.4M
Long-term liabilities	$44,000
Net cash (debt)	$5M
Net cash / market cap	89.18%
Net cash growth	-61.65%
Net debt / equity	-2.97
Piotroski F-Score	0
Property, plant and equipment	$5,000
Shareholders' equity	$1.7M
Tangible book value	$-750,000
Tangible book value per share	$-0.05
Total assets	$11.5M
Total cash	$5M
Total debt	$0
Total liabilities	$9.8M
WACC	12.64%

Metric

Value

Altman Z-Score

-84.72

Book value per share

$0.11

Debt / equity

Long-term assets

$2.4M

Long-term liabilities

$44,000

Net cash (debt)

$5M

Net cash / market cap

89.18%

Net cash growth

-61.65%

Net debt / equity

-2.97

Piotroski F-Score

Property, plant and equipment

$5,000

Shareholders' equity

$1.7M

Tangible book value

$-750,000

Tangible book value per share

$-0.05

Total assets

$11.5M

Total cash

$5M

Total debt

Total liabilities

$9.8M

WACC

12.64%

Metric	Value
Current assets	$9M
Current liabilities	$9.7M
Current ratio	0.93
Net working capital	$-5.7M
Quick ratio	0.87
Working capital	$-712,000

Metric

Value

Current assets

$9M

Current liabilities

$9.7M

Current ratio

0.93

Net working capital

$-5.7M

Quick ratio

0.87

Working capital

$-712,000

Metric	Value
Buyback yield / dilution	-138.41%
Dividend yield	0%
Shareholder yield	-138.41%

Metric

Value

Buyback yield / dilution

-138.41%

Dividend yield

Shareholder yield

-138.41%

Metric	Value
10Y price change	-100%
10Y return CAGR	-65.4%
10Y total return	-100%
150-day SMA	$0.92
1D price change	-3.61%
1M price change	-37.86%
1M total return	-37.86%
1W price change	-6.91%
1W total return	-6.91%
1Y price change	-86.54%
1Y return CAGR	-86.56%
1Y total return	-86.54%
20-day SMA	$0.42
200-day SMA	$1.18
3M price change	-32.69%
3M total return	-32.69%
3Y price change	-97.74%
3Y return CAGR	-71.73%
3Y total return	-97.74%
50-day SMA	$0.50
50-day SMA vs 200-day SMA	50under200
52-week high	$3.23
52-week high date	2026-05-11
52-week low	$0.31
52-week low date	2026-10-27
5Y price change	-99.58%
5Y return CAGR	-66.61%
5Y total return	-99.58%
6M price change	-69.3%
6M total return	-69.3%
All-time high	$1,751,060.31
All-time high date	2013-10-04
All-time low	$0.31
All-time low date	2026-10-27
Average true range (ATR)	$0.04
Average volume	150K
Beta (1Y)	0.83
Beta (2Y)	0.59
Beta (5Y)	1.53
Change from 52-week high	-89.08%
Change from 52-week low	13.81%
Change from all-time high	-100%
Change from all-time low	12.9%
Change from open	-1.15%
Day's gap	-2.49%
Dollar volume	$9,744
High price	$0.36
Low price	$0.35
Monthly RSI	27.08
Open price	$0.36
Position in 52-week range	0%
Premarket change	-1.64%
Premarket close	$0.37
Premarket price	$0.36
Previous close	$0.37
Price vs 150-day SMA	-61.94%
Price vs 20-day SMA	-17.26%
Price vs 200-day SMA	-70.34%
Price vs 50-day SMA	-30.08%
Relative volume	0.18
RSI	31.2
Sharpe ratio	-0.96
Sharpe ratio (3Y)	-0.41
Sharpe ratio (5Y)	-0.47
Sortino ratio	-1.27
Sortino ratio (3Y)	-0.68
Sortino ratio (5Y)	-0.76
Volume	27.6K
Weekly RSI	34.14
YTD price change	-69.03%
YTD total return	-69.03%

Metric

Value

10Y price change

-100%

10Y return CAGR

-65.4%

10Y total return

-100%

150-day SMA

$0.92

1D price change

-3.61%

1M price change

-37.86%

1M total return

-37.86%

1W price change

-6.91%

1W total return

-6.91%

1Y price change

-86.54%

1Y return CAGR

-86.56%

1Y total return

-86.54%

20-day SMA

$0.42

200-day SMA

$1.18

3M price change

-32.69%

3M total return

-32.69%

3Y price change

-97.74%

3Y return CAGR

-71.73%

3Y total return

-97.74%

50-day SMA

$0.50

50-day SMA vs 200-day SMA

50under200

52-week high

$3.23

52-week high date

2026-05-11

52-week low

$0.31

52-week low date

2026-10-27

5Y price change

-99.58%

5Y return CAGR

-66.61%

5Y total return

-99.58%

6M price change

-69.3%

6M total return

-69.3%

All-time high

$1,751,060.31

All-time high date

2013-10-04

All-time low

$0.31

All-time low date

2026-10-27

Average true range (ATR)

$0.04

Average volume

150K

Beta (1Y)

0.83

Beta (2Y)

0.59

Beta (5Y)

1.53

Change from 52-week high

-89.08%

Change from 52-week low

13.81%

Change from all-time high

-100%

Change from all-time low

12.9%

Change from open

-1.15%

Day's gap

-2.49%

Dollar volume

$9,744

High price

$0.36

Low price

$0.35

Monthly RSI

27.08

Open price

$0.36

Position in 52-week range

Premarket change

-1.64%

Premarket close

$0.37

Premarket price

$0.36

Previous close

$0.37

Price vs 150-day SMA

-61.94%

Price vs 20-day SMA

-17.26%

Price vs 200-day SMA

-70.34%

Price vs 50-day SMA

-30.08%

Relative volume

0.18

RSI

31.2

Sharpe ratio

-0.96

Sharpe ratio (3Y)

-0.41

Sharpe ratio (5Y)

-0.47

Sortino ratio

-1.27

Sortino ratio (3Y)

-0.68

Sortino ratio (5Y)

-0.76

Volume

27.6K

Weekly RSI

34.14

YTD price change

-69.03%

YTD total return

-69.03%

Metric	Value
Float	13M
Float percentage	84.44%
Shares change (QoQ)	49.09%
Shares change (YoY)	138.41%
Shares held by insiders	6.51%
Shares held by institutions	27.23%
Shares outstanding	15.4M
Short % of float	5.32%
Short % of shares	4.49%
Short ratio	0.5 days

Metric

Value

Float

13M

Float percentage

84.44%

Shares change (QoQ)

49.09%

Shares change (YoY)

138.41%

Shares held by insiders

6.51%

Shares held by institutions

27.23%

Shares outstanding

15.4M

Short % of float

5.32%

Short % of shares

4.49%

Short ratio

0.5 days

Traws Pharma, Inc. (TRAW)

Price

Financial snapshot

Fair-value bridge

Latest news · TRAW

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TRAW indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on TRAW

Frequently asked questions